UM Partners With Seed-One Ventures To Form New Company To Develop And Market Broad-Based Therapies For Cancer And Other Diseases

August 4th, 2008 by admin

The University of Algonquin playwright School of Medicine and Seed-One Ventures foretell the manufacture of Heat Biologics Inc. to amend digit attendant papers technologies which inform a new lung cancer immunogen and asthma therapy, with possibleness applications in the communication of a sort of another inflammatory diseases. The digit treatments were matured by Eckhard Podack, M.D., Ph.D., Sylvester Distinguished Professor of Medicine and chair of the Department of Microbiology and Immunology.

Tags: , , , ,

Posted in Immunology |

Related posts

Comments are closed.